
[ad_1]

Dubai – WAM
The UAE Health Services Corporation, represented by the Ministry of Primary Healthcare, announced that it has launched a campaign in partnership with the company ‘iCare’ for the early detection of diabetic retinopathy in patients, testing 1,000 patients in each of the emirates of Umm Al Quwain, Ras Al Khaimah and Fujairah using artificial intelligence technology in an effort to improve the health of the community, raise their awareness levels, prevent diseases, improve the quality of life of patients with diabetes and provide them with the best healthcare.
The campaign aims to increase awareness and prevention of eye diseases and provide the best healthcare to diabetic patients while improving the efficiency level of early screening in non-communicable disease clinics.
The campaign relies on a digital mechanism to capture retinal images and analyse them through advanced artificial intelligence technology, which allows the detection of signs and symptoms of retinal diseases, including diabetic retinopathy, age-related macular degeneration and glaucoma, and diagnoses them with high accuracy at an early stage, ensuring that the impact of these diseases is reduced.
Dr. Sujoud Al Sharif, Director of Non-Communicable Diseases Programme at the Emirates Health Services Corporation, stressed the growing interest in early and proactive detection of diseases, especially those associated with chronic conditions that threaten vision loss, such as diabetic retinopathy. The initiative, based on the use of artificial intelligence technology, aims to enhance the UAE’s healthcare system to provide excellent medical services, help prevent eye diseases and improve the health and well-being of people with diabetes.
She explained that the technology is used to detect diabetic retinopathy, one of the complications of diabetes and one of the leading causes of vision loss, by using a specialized camera to photograph the retina and take accurate photos of the patient’s eyes, which can then be examined and evaluated through artificial intelligence, thus detecting early signs and indicators of diabetic patients’ retinopathy, pointing out that due to the quality of this technology, ophthalmologists are able to detect these complications at an early stage, ensuring that appropriate treatment measures are taken and treatment is provided at the right time.
[ad_2]
Source link